U.S. Congress reaches agreement for Ukraine aid, government funding bill
Reuters
Published Mar 09, 2022 03:49AM ET
(Reuters) - U.S. congressional leaders reached a bipartisan agreement early on Wednesday to allocate $13.6 billion in emergency aid for Ukraine and provide $15.6 billion to fight the COVID-19 pandemic.
The sweeping legislation will provide $1.5 trillion for defense and non-defense discretionary spending and fund the federal government through Sept. 30.
"We can’t stay away from the TV and watching what is happening in Ukraine ... and this bill responds to Russia’s unprovoked war of aggression (and) vicious invasion of Ukraine," Rosa DeLauro, the House Appropriations Committee chair, said in a statement.
Congress faces a midnight Friday deadline to pass the legislation.
House of Representatives Majority Leader Steny Hoyer told reporters earlier on Tuesday that his chamber is aiming to debate and pass legislation on Wednesday.
But he left open the possibility of a short-term stop-gap bill being needed if legislation providing full government funding is not completed in time.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.